Insider Selling: 908 Devices (NASDAQ:MASS) SVP Sells $130,989.00 in Stock

908 Devices Inc. (NASDAQ:MASS) SVP Kevin Mccallion sold 18,580 shares of the firm’s stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $7.05, for a total transaction of $130,989.00. Following the sale, the senior vice president owned 44,925 shares of the company’s stock, valued at approximately $316,721.25. This represents a 29.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Performance

NASDAQ MASS opened at $7.14 on Monday. The firm has a 50-day moving average of $6.47 and a 200-day moving average of $6.66. The stock has a market cap of $266.89 million, a PE ratio of 12.98 and a beta of 0.54. 908 Devices Inc. has a 52-week low of $3.79 and a 52-week high of $9.34.

908 Devices (NASDAQ:MASS) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.01. The company had revenue of $17.38 million during the quarter, compared to analysts’ expectations of $16.19 million. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. As a group, analysts predict that 908 Devices Inc. will post -1.99 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have weighed in on MASS. Wall Street Zen upgraded shares of 908 Devices from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of 908 Devices in a research note on Wednesday, January 21st. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $12.00.

Key Headlines Impacting 908 Devices

Here are the key news stories impacting 908 Devices this week:

• Neutral Sentiment: SVP Kevin J. McCallion sold 18,580 shares on April 8 at an average $7.05 (proceeds $130,989). The sale was executed under a Rule 10b5‑1 plan and left him with 44,925 shares. Form 4
• Neutral Sentiment: SVP Kevin J. McCallion sold an additional 5,420 shares on April 9 at an average $7.03 (proceeds ~$38.1k), also under a 10b5‑1 plan. He still holds 44,925 shares. Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 17,578 shares on April 10 at $7.07 (proceeds ~$124.3k), under a 10b5‑1 plan; he remains a large holder (~945,559 shares). Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 7,392 shares on April 9 at $7.04 (proceeds ~$52.0k), and 15,030 shares on April 8 at $7.05 (proceeds ~$106.0k); all under a 10b5‑1 plan. Form 4
• Neutral Sentiment: Reported short interest shows 0 shares (as of April 10), implying no measurable short pressure; the short‑interest ratio is effectively 0.0 days based on average volume. Source data flagged anomalous/NaN changes.
• Negative Sentiment: Combined impact: insiders sold ~64,000 shares this week for roughly $450k in proceeds. Even though sales were via 10b5‑1 plans (which mutes informational content), the concentrated volume of insider selling can create near‑term downward pressure or raise investor questions about insider liquidity needs.

Institutional Trading of 908 Devices

Several hedge funds and other institutional investors have recently bought and sold shares of the business. First Light Asset Management LLC raised its stake in 908 Devices by 92.6% in the 4th quarter. First Light Asset Management LLC now owns 4,836,186 shares of the company’s stock worth $25,390,000 after purchasing an additional 2,325,690 shares in the last quarter. ARK Investment Management LLC raised its position in shares of 908 Devices by 1.6% in the 4th quarter. ARK Investment Management LLC now owns 1,985,986 shares of the company’s stock valued at $10,426,000 after buying an additional 32,214 shares in the last quarter. Needham Investment Management LLC raised its position in shares of 908 Devices by 246.8% in the 4th quarter. Needham Investment Management LLC now owns 770,000 shares of the company’s stock valued at $4,042,000 after buying an additional 548,000 shares in the last quarter. Geode Capital Management LLC raised its position in shares of 908 Devices by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 688,566 shares of the company’s stock valued at $3,616,000 after buying an additional 16,477 shares in the last quarter. Finally, Marshall Wace LLP raised its position in shares of 908 Devices by 359.4% in the 2nd quarter. Marshall Wace LLP now owns 648,796 shares of the company’s stock valued at $4,626,000 after buying an additional 507,562 shares in the last quarter. Institutional investors and hedge funds own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.